[go: up one dir, main page]

ES2073393T3 - Derivados de acidos 2,4- y 2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de los mismos asi como medicamentos a base de estos compuestos. - Google Patents

Derivados de acidos 2,4- y 2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de los mismos asi como medicamentos a base de estos compuestos.

Info

Publication number
ES2073393T3
ES2073393T3 ES88101791T ES88101791T ES2073393T3 ES 2073393 T3 ES2073393 T3 ES 2073393T3 ES 88101791 T ES88101791 T ES 88101791T ES 88101791 T ES88101791 T ES 88101791T ES 2073393 T3 ES2073393 T3 ES 2073393T3
Authority
ES
Spain
Prior art keywords
derivatives
compounds
procedure
well
dicarboxilicos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88101791T
Other languages
English (en)
Inventor
Martin Dr Bickel
Dietrich Dr Brocks
Harald Dr Burghard
Volkmar Dr Gunzler
Stephan Dr Henke
Hartmut Dr Hanauske-Abel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2073393T3 publication Critical patent/ES2073393T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A DERIVADOS DE ACIDO PIRIDIN -2,4 Y 2,5 DICARBOXILICO DE FORMULA (I), EN LA QUE R1, R2 Y X TIENEN EL SIGNIFICADO QUE SE INDICA, UN PROCEDIMIENTO PARA LA OBTENCION DE ESTOS COMPUESTOS ASI COMO SU APLICACION EN PARTICULAR EN MEDICAMENTOS PARA INFLUIR SOBRE EL METABOLISMO DEL COLAGENO Y SUSTANCIAS SEMEJANTES AL COLAGENO, O SOBRE LA BIOSINTESIS DE C1Q.
ES88101791T 1987-02-10 1988-02-08 Derivados de acidos 2,4- y 2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de los mismos asi como medicamentos a base de estos compuestos. Expired - Lifetime ES2073393T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873703963 DE3703963A1 (de) 1987-02-10 1987-02-10 Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen

Publications (1)

Publication Number Publication Date
ES2073393T3 true ES2073393T3 (es) 1995-08-16

Family

ID=6320593

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88101791T Expired - Lifetime ES2073393T3 (es) 1987-02-10 1988-02-08 Derivados de acidos 2,4- y 2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de los mismos asi como medicamentos a base de estos compuestos.

Country Status (17)

Country Link
EP (1) EP0278452B1 (es)
JP (1) JPS63216870A (es)
KR (1) KR960011371B1 (es)
AR (1) AR247816A1 (es)
AT (1) ATE123022T1 (es)
AU (1) AU600084B2 (es)
DE (2) DE3703963A1 (es)
DK (2) DK168379B1 (es)
ES (1) ES2073393T3 (es)
FI (1) FI91524C (es)
HU (1) HU207295B (es)
IE (1) IE67446B1 (es)
IL (1) IL85361A (es)
NO (1) NO173184C (es)
NZ (1) NZ223431A (es)
PT (1) PT86734B (es)
ZA (1) ZA88897B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3707429A1 (de) * 1987-03-07 1988-09-15 Hoechst Ag Substituierte pyridin-2,4-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
HU202516B (en) * 1987-10-02 1991-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producing (2-thenyl)-thiourea derivatives and yield increasing agents comprising such compounds
DE3924093A1 (de) 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE3938805A1 (de) * 1989-11-23 1991-05-29 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE4020570A1 (de) 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung
US5260323A (en) * 1990-06-28 1993-11-09 Hoechst Aktiengesellschaft 2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and their use
DE4030999A1 (de) * 1990-10-01 1992-04-09 Hoechst Ag 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
YU9492A (sh) * 1991-02-05 1995-03-27 Hoechst Ag. 2,4- i 2,5-bis-tetrazolilni piridini i postupak za njihovo dobijanje
EP0548883A1 (de) * 1991-12-24 1993-06-30 Hoechst Aktiengesellschaft Substituierte Pyridin-N-oxide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
TW352384B (en) * 1992-03-24 1999-02-11 Hoechst Ag Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
DE4233124A1 (de) * 1992-10-02 1994-04-07 Hoechst Ag Acylsulfonamido- und Sulfonamidopyridin-2-carbonsäureester sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO1999021860A1 (en) * 1997-10-24 1999-05-06 Fibrogen, Inc. Phenanthroline derivatives
KR100579792B1 (ko) * 1998-05-13 2006-05-12 동화약품공업주식회사 신규 2,5-피리딘디카복실산 유도체

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093622A (en) * 1975-05-19 1978-06-06 Zoecon Corporation Pyridine esters of cyclopropane-carboxylic acid
EP0123700A1 (de) * 1983-04-27 1984-11-07 Byk Gulden Lomberg Chemische Fabrik GmbH Substituierte Picolinsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
DE3432094A1 (de) * 1984-08-31 1986-03-06 Hoechst Ag, 6230 Frankfurt Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
US4757071A (en) * 1984-12-14 1988-07-12 Nisshin Flour Milling Co., Ltd. 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases
US4691018A (en) * 1985-05-23 1987-09-01 Chugai Seiyaku Kabushiki Kaisha Pyridine derivatives and their use as anti-allergic agents
GB8702890D0 (en) * 1987-02-10 1987-03-18 Zyma Sa Heterocyclic compounds
ES2065355T3 (es) * 1988-08-04 1995-02-16 Hoechst Ag Procedimiento mejorado para la preparacion de n,n'-bis (alcoxialquil)-diamidas de acidos piridina-2,4-dicarboxilicos.

Also Published As

Publication number Publication date
AU1145088A (en) 1988-08-11
DK170245B1 (da) 1995-07-17
DK66088A (da) 1988-08-11
PT86734B (pt) 1992-05-29
KR880009935A (ko) 1988-10-05
JPS63216870A (ja) 1988-09-09
NO173184B (no) 1993-08-02
FI880554A0 (fi) 1988-02-08
FI880554A7 (fi) 1988-08-11
AU600084B2 (en) 1990-08-02
IL85361A0 (en) 1988-07-31
ZA88897B (en) 1988-08-09
NO880556L (no) 1988-08-11
NO173184C (no) 1993-11-10
FI91524B (fi) 1994-03-31
DK90992A (da) 1992-07-10
DK90992D0 (da) 1992-07-10
ATE123022T1 (de) 1995-06-15
EP0278452A2 (de) 1988-08-17
HU207295B (en) 1993-03-29
DK66088D0 (da) 1988-02-09
EP0278452A3 (en) 1989-10-18
IE67446B1 (en) 1996-04-03
IL85361A (en) 1993-01-31
EP0278452B1 (de) 1995-05-24
NO880556D0 (no) 1988-02-09
DK168379B1 (da) 1994-03-21
FI91524C (fi) 1994-07-11
IE880350L (en) 1988-08-10
HUT47249A (en) 1989-02-28
DE3853839D1 (de) 1995-06-29
PT86734A (pt) 1988-03-01
NZ223431A (en) 1990-07-26
KR960011371B1 (ko) 1996-08-22
DE3703963A1 (de) 1988-08-18
AR247816A1 (es) 1995-04-28

Similar Documents

Publication Publication Date Title
ES2067448T3 (es) Amidas de acidos piridina-2,4- y -2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de las mismas, asi como medicamentos a base de estos compuestos.
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2079694T3 (es) Derivados de bifenilo, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2042737T3 (es) Un procedimiento para la preparacion de un glucosido de antraciclina.
SV1999000118A (es) Nuevos derivados de pirazol substituidos ref. lea 33188-sv
ES2062239T3 (es) Diamidas de acidos pirimidin-4,6-dicarboxilicos, procedimiento para su preparacion, utilizacion de las mismas, asi como medicamentos a base de estos compuestos.
ES2065324T3 (es) N-(piridinil)-1h-indol-1-aminas, un procedimiento para su preparacion y su uso como medicamentos.
ES2073393T3 (es) Derivados de acidos 2,4- y 2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de los mismos asi como medicamentos a base de estos compuestos.
ES2110003T3 (es) Nuevas composiciones a base de derivados de la clase de los taxanos.
ES2054716T3 (es) Bis-naftalimidas, su obtencion y empleo.
ECSP055746A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
ES2036177T3 (es) Maltitol en polvo directamente compresible y su procedimiento de preparacion.
ES2037753T3 (es) Compuestos heterociclicos y su preparacion y uso.
ES2080764T3 (es) Derivados de acidos biliares fluorados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
MX9400082A (es) Derivados de cumarina como inhibidores retrovirales.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
MX168030B (es) Procedimiento para la preparacion de derivados de alcano y alcoxialcano
ES2046218T3 (es) Derivados de acidos piridin-2,4- y -2,5-dicarboxilicos, procedimientos para su produccion, aplicacion de los mismos asi como medicamentos a base de estos compuestos.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
GT199900113A (es) Inhibidores de las fkbp.
ES2061550T3 (es) Vinilcefalosporinas substituidas, procedimiento para su preparacion y su uso como medicamento.
ES2097924T3 (es) 14,17-etano-estratrienos sustituidos en posicion 11beta, procedimiento para la preparacion de estos compuestos, asi como su utilizacion para la preparacion de medicamentos.
ES2060800T3 (es) Nuevos compuestos triyodobencenicos no ionicos yodados y productos de contraste que los contienen.
ES2059444T3 (es) Procedimiento para la obtencion de acroleinas alfa,beta-substituidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 278452

Country of ref document: ES